Endocrine System Flashcards
What is the mechanism of action of metformin?
Decreases glucoseneogenesis and increases peripheral utilisation of glucose
(Acts only in the presence of insulin = only effective when there is some functioning of pancreases cells)
THEREFORE DOESNT CAUSE HYPOGLYCAEMIA as doesn’t stimulate insulin secretion
Dose of metformin
Type II; MAX 2g per day
MR versions to prevent stomach issues
Polycystic ovary syndrome
First choice for all patients
Metformin contraindication
Acute metabolic acidosis including lactic acidosis and ketoacidosis
EGFR <30 mL/min/1.73 m2 or <45 mL/min.1.73 m2 for MR versions
Risk factors for lactic acidosis
HF or recent MI
Alcohol intoxication
Renal impairment
Respiratory failure
Dehydration
Fasting
Liver impairment
Ketosis
Adverse effects of Metformin
GI disorders; abdominal pain, diarrhoea, decreased appetite, altered taste
Consider switch to MR Or slow dose increase
Lactic acidosis risk
Decrease B12 absorption
Weight loss
Taste disturbances
Symptoms of lactic acidosis
Dyspnoea
Muscle cramps
Abdominal pain
Hypothermia
Asthenia
Mechanism of action of sulphonylurea?
Stimulates the release of insulin from pancreatic beta cells therefore decreasing the concentration of glucose
RISK OF HYPOGLYCAEMIA
Adverse effects of Sulphonylurea?
Weight gain
GI disturbances
Hypoglycaemia (greater risk with long acting)
Hepatic impairment (jaundice, hepatitis, hepatic failure)
Allergic skin reaction in first 6-8 wks
Long acting Sulphonylurea
Glibenclamide
Glimepiride
Short acting sulphonylurea
Gliclazide
Tolbutamide
Glipizide
Gliclazide advantage
Metabolised by liver therefore can be used in renal impairment patients
Short acting = lower risk of hypos
Caution and CI in sulphonylureas
Elderly patients - best to give short acting
Patients with G6PD deficiency
Acute porphyria
Ketoacidosis
Avoid/reduce dose in renal impairment
Given if metformin is CI as first line and pt is not overweight
How do you take sulphonylureas?
With or immediately after breaskfast
sulphonylurea interactions?
Warfarin and ACEi increase the risk of hypos
NSAIDs decrease renal excretion
Alpha glucosidase inhibitors mechanism of action and example?
Acarbose
Inhibits alpha glucosidase. Delays digestion and absorption stage of sucrose
Poorer anti diabetic medication
What do you give is pt is in acarbose and is having a hypo?
Give glucose
Interferes with sucrose absorption therefore give glucose
Side effects of alpha glucosidase inhibitor?
Flatulence
Diarrhoea
Pioglitazone mechanism of action?
Is a thiazolidinedione
Reduces insulin resistance leading to reduction in blood glucose concentration
(Enhances action as it increases insulin sensitivity in tissues = reduces blood glucose)
Pioglitazone side effects?
Bone fracture
Weight gain
Visual impairmentt
Increase infection risk
Nausea
Thirst
Urinary disorders
MHRA alerts for Pioglitazone
CV safety; HF (symptoms; fluid retention, weight gain)
Risk of bladder cancer (symptoms; haematuria, dysuria, urinary urgency)
Patient and carer advise for pioglitazone
Report signs of liver toxicity
Unexplained N&V
Abdominal pain
Fatigue
Anorexia
Dark urine
Contraindications for pioglitazone?
bladder cancer history
Liver impairment
HF
Haematuria
Pioglitazone interactions
Clopidogrel can increase pioglitazone exposure = severe interaction
Pioglitazone monitoring
Signs and symptoms of fluid retention (weight gain or oedema)
Liver functions (hepatotoxic / toxicity)
DPP4-I (Gliptins) mechanism of actions?
Inhibition of DPP-4 increases insulin secretion and lowers glucagon secretion
(Helps increase insulin as it prevents incretin breakdown by DPP-4 which produced insulin)
Examples of DD4-I (gliptins)?
Alogliptin, linagliptin, sitagliptin, saxagliptin and vindagliptin
Adverse effects of gliptins?
Increased risk of upper respiratory tract infections
Discontinue if severe abdominal pain = sign of pancreatitis
GI disturbances
Skin reactions
Contraindication with gliptins?
Ketoacidosis
Renal and hepatic impairment when using gliptins?
Dose adjustment is necessary for all gliptins EXCEPT LINAGLIPTIN
Gliptins interaction?
With combination of sulfonylureas use lower dose to decrease risk of hypos
SGLT-2 I mechanism of action?
Reduce glucose re absorption and increase glucose excretion via urine
Examples of SGLT2-I?
Canagliflozin, dapagliflozin and empafiglozin
MRHA alerts with SGLT2-I?
Fournier gangrene
Canafliglozin specific ; lower limb amputation
Risk life threatening DKA
Monitor blood ketone levels during treatment interruption for surgical procedures or acute medical treatment
Fournier gangrene
Report; severe pain, tenderness, erythema, or swelling in the genital or perineal area
Accompanied by fever or malaise urogenital infection or perineal abscess may precede necrotising fasciitis
Risk of lower limb amputation with canagliflozin
Mainly toes
Consider stopping if pt develops lower limb complications
Start treatment of lower limb complications ASAP
Advise patients to stay well hydrated
DKA risk
Symptoms; dry skin/mouth, flushed face, headache, confusion, tried, sleepiness blurred vision
Test for ketones
Discontinue if suspected cause is SGLT2-I - not to continue
Discontinue during acute illness / surgery
Side effects of SGLT-2I?
Genital infections ; UTI risk
Polyuria
Thirst
GLP1 mimetic mechanism of action?
Increase insulin secretion and suppresses glycogen secretion whilst also delaying gastric emptying
When is GLP1 mimetics used?
For combination therapy when other treatment options have failed
Review 3 months; 3% weight reduction
Can be if triple therapy has has failed
When should you continue pioglitazone?
If HBA1c has decreased by 0.5% within 6 months of starting treatment
Adverse effects of GLP1 mimetics?
GI discomfort
Pancreatitis then discontinue permanently
MHRA alert GLP1 mimemtics
Serious life threatening DKA risk concomitant insulin therapy was rapidly reduced
Contraindications GLP1 mimetics
Ketoacidosis
Renal impairment
Severe GI disease
EGFR < 30
Liraglutide avoid IBD, diabetic gastroparesis, hepatic impairment and mod-severe HF
Contraception and GLP1 mimetics?
Contraception must be used during treatment with exenatide or lixisenatide and for 12 weeks after stopping MR exenatide
How to take GLP1 mimetics?
Take oral medication 1 hour before OR 4 hours after dose
Administer before a meal
IR should be injected daily or MR at weekly intervals
Rapid acting analogue insulin
Insulin aspart (fiasp and novo rapid)
Insulin glutisine (apidra)
Insulin lispro (Humalog)
Faster onset of action within 15 mins lasts for 2 to 5 hours
Given S/C before meals
Shorter duration of action than soluble insulin (better than soluble for glycaemic control, reduction in Hba1c and hypo incidence)
Soluble (short acting) insulin
Actrapid (Human Actrapid)
Humulin S
Hypurin bovine/porcine
Insuman
Acts within 30 to 60 mins lasting up to 9 hours
Preffered in emergencies (IV instant onset)
Animal insulin
Intermediate acting insulin
Isophane insulin (Humilin I)
Intermediate duration of action
Mimics the effect of basal insulin
1-2 hours onset with action go 11-24 hours
Can be mixed with other insulin
Isophane + (insulin + protamine) = e.g Novo mix, M3
Premixed or biphasic
Protamine is fish so can cause allergic reaction
Biphasic
Intermediate acting insulin + short acting insulin
Novomix 30
Humalog Mix 25 and 50
Humulin M3
Long acting insulin
Determir (Levemir) - given OD or BD
Glargine (lantus, toujeo) OD
Degludec (Tresiba) OD
May last up to 36 hours
Mainly adjuvant to type II diabetic treatment
Management of diabeties
Weight, BP, smoking status, HBA1c, urinary albumin, creatinine, cholesterol, eyes, foot, thyroid disease
What is basal bolus insulin regimen?
Multiple daily injections
Preferred especially if patient is newly diagnosed (1st choice)
Must match carbohydrate intake
Offered flexibility to tailor insulin therapy with carbohydrate load of each meal
- ONE or more separate daily injection of long acting or intermediate as basal
AND
- multiple bolus injections of short acting insulin before meals
What is a mixed (Biphasic) regiment?
One, two or three insulin injections per day as short acting and intermediate
Can be mixed by patient or pre-mixed
Pre mixed analogue insulins (rapid acting + intermediate) e.g Humalog Mix 25, 50 and novo mix
Premixed human insulin (soluble insulin + intermediate) e.g humulin M2, M3 M5 insuman comb 15/20/50
Not recommended in newly diagnosed type I; as insulin is fixed not change dose (can’t adjust) new diagnosed = no flexibility not soluble.
What is a continuous S/C insulin infusion (insulin pump)?
Regular or continuous amount of insulin
Usually rapid acting analogue or soluble insulin
Delivered by programmable pump and insulin reservoir via cannula or subcut needle
Only for adults who suffer from disabling hypoglycaemia or high HBA1c (69 mol/mol +)
Initiated by specialists
What can cause poor glucose control?
Adherence, injection technique, injection site problem
Blood glucose monitoring skills, lifestyle issues (diet, alcohol, exercise)
Psychological issues, renal disease, thyroid disorders
What can decrease insulin requirements?
Physical activity, inter current illness (diarrhoea, vomiting = increases glucose excretion), reduce food intake, impaired renal function, certain endocrine disorders (Addison disease, coeliac)
LOWER DOSE REQUIRED OR CAN CAUSE HYPO
What can increase insulin requirements?
Infection, stress, accidental or surgical trauma
Pregnancy (2nd and 3rd) and puberty
HIGHER DOSE REQUIRED OR HYPER
How to administer insulin?
Inject with area with most S/C fat (e.g abdomen is fastest absorption route) or outer thigh/buttock
Rotate site of injection or lipohypertrophy risk
Check injection sites for signs of injection, swelling, bruising and lipohypertrophy
Type II diabeties
Insulin deficiency or resistance
Associated with obesity, physical inactivity, raised BP, dylipidaemia and tendency to develop thrombosis it increases CV risk
Associated with long term micro vascular and macro vascular complications
Typically develop later in life but is increasingly being diagnosed in children
What is the target HBA1c with single drug (not with sulphonylurea)?
48 mmol
What is target HBA1c with 2+ drugs or sulphonylurea?
53 mmol
What is first step monotherapy?
Lifestyle and dietary fail
HBA1c is 48 mmol
Give metformin (gold standard)
IR or MR and increase in intervals
If metformin is CI give DDP4I, sulphonylurea or pioglitazone
What is the first intensification of treatment (DUAL THERAPY)?
If metformin with lifestyle changes is not effective the ADD;
Sulphonylurea, pioglitazone, DPP4I or SGLT2
What is the second intensification treatment (TRIPLE THERAPY)?
If dual therapy is unsuccessful ADD a third drug;
Metformin + DPP4I + sulphonylurea
Metformin + pioglitazone + sulphonylurea
Metformin + sulphonylurea + SGLT2
Metformin + pioglitazone + SGLT2 ( NOT DAPAGLIFAZONE)
May start insulin programme at this stage
What shouldn’t dapagliflozin be used with?
SGLT2I dapagliflozin shouldn’t be used with pioglitazone as it increased hypo risk
Dapagliflozin is also licensed with HF with reduced ejection fraction
Symptoms of hypoglycaemia?
Shaking trembling
Sweating
Pins and needles in lips and tongue
Hunger
Palpitations
Headahe
Double vision
Difficulty concentration, confusion, change in behaviour, slurred speech, convulsions = EMERGENCY
What class of drugs masks hypoglycaemia signs?
Beta blockers
What is disadvantage of tight glycaemic control and hypoglycaemia?
Lowers the level needed to trigger hypo signs/symptoms
Avoid frequent hypo episodes to restore warning signs
What is the management of hypoglycaemia?
Initially 10-20 g sugar (liquid is absorbed faster)
Lucazade, cocoa cola (100 mL), Ribera, glycogen dextrogel
If patient is unconscious glucagon 1 mg (IM or SC) - transfer urgent to hospital
Admit to hospital if hypo is caused by oral anti diabetic especially SGLT2I as it can persist for hours
What foods should you avoid if your diabetic?
Fat sugary food
Fat will delay absorption of glucose and lengthen the time of glucose release = longer period of time of glucose release
Diabetics and CVD risk?
Increase risk factor
Address other factors e.g smoking, hypertension, obesity and hyperlipidemia (QRISK >10% give statin)
Reduce risk ACEi , lipid regulating drugs and low dose aspirin (if required for secondary prevention)
What is diabetic nephropathy?
Kidney damage
Test for urinary protein and serum creatinine
Urine microalbuminuria; earliest signs problems with filtrations
ALL patients should be given ACEi (or ARB if CI) even if Afro-Caribbean
ACEi can potential hypo effects of drugs + insulin esp renal impairment